Johnson & Johnson (JNJ)

169.99
-0.60(-0.35%)
  • Volume:
    3,197,978
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    169.30 - 170.99

JNJ Overview

Prev. Close
170.59
Day's Range
169.3-170.99
Revenue
93.78B
Open
170.8
52 wk Range
151.47-179.92
EPS
7.81
Volume
3,197,978
Market Cap
448.7B
Dividend (Yield)
4.24
(2.49%)
Average Volume (3m)
7,642,979
P/E Ratio
21.83
Beta
0.69
1-Year Change
1.61%
Shares Outstanding
2,632,596,969
Next Earnings Date
18 Apr 2022
What is your sentiment on Johnson & Johnson?
or
Vote to see community's results!

Johnson & Johnson Company Profile

Employees
134500

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women’s health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyBuyStrong BuyStrong Buy
Technical IndicatorsBuySellStrong BuyStrong BuyStrong Buy
SummaryNeutralNeutralStrong BuyStrong BuyStrong Buy
  • FDA approved finally. Few minutes ago!!!!
    0
    • What?
      0
  • Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
    0
    • To entry in Spectrum or not? What do you think?
      0
    • Checking it out looks like a good punt
      0
  • Good job JNJ. move forward bullish
    0
    • Stock split???
      0
      • Where we go next?
        0
        • AMC! But ultimately it’s your decision.
          0
      • Good buy. 0at this price
        0
        • JNJ is going to Make a strong come back tonight!
          1
          • Immediate inquiry must be done
            4
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.